CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

NCT05685602 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

43

Enrollment

NIH

Sponsor class

Stopped Drug Supply Issues

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8
Unresectable Pancreatic Ductal Adenocarcinoma

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Emavusertib
DRUG: Gemcitabine Hydrochloride
DRUG: Nab-paclitaxel

Sponsor

National Cancer Institute (NCI)